Cefpodoxime proxetil and Multi-organ failure - a phase IV clinical study of FDA data

Summary:

Multi-organ failure is reported as a side effect among people who take Cefpodoxime proxetil (cefpodoxime proxetil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Camptosar, and have Colorectal cancer metastatic.

The phase IV clinical study analyzes which people have Multi-organ failure when taking Cefpodoxime proxetil. It is created by eHealthMe based on reports of 1,308 people who have side effects when taking Cefpodoxime proxetil from the FDA, and is updated regularly.

What is Cefpodoxime proxetil?

Cefpodoxime proxetil has active ingredients of cefpodoxime proxetil. eHealthMe is studying from 1,357 Cefpodoxime proxetil users. Check the latest studies of Cefpodoxime proxetil.

What is Multi-organ failure?

Multi-organ failure (multisystem organ failure) is found to be associated with 1,384 drugs and 2,281 conditions by eHealthMe. Check the latest studies of Multi-organ failure.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

1,308 people reported to have side effects when taking Cefpodoxime proxetil.
Among them, 11 people (0.84%) have Multi-organ failure.

Could Cefpodoxime proxetil cause Multi-organ failure?

Among these 11 people:

How long have people been on Cefpodoxime proxetil when they have Multi-organ failure? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Multi-organ failure when taking Cefpodoxime proxetil? *

  • female: 81.82 %
  • male: 18.18 %

What is the age of people who have Multi-organ failure when taking Cefpodoxime proxetil? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 20 %
  • 20-29: 0.0 %
  • 30-39: 10 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 70 %

What are other drugs people take besides Cefpodoxime proxetil? *

  1. Camptosar: 4 people, 36.36%
  2. Fluconazole: 2 people, 18.18%
  3. Celebrex: 2 people, 18.18%
  4. Claritin: 2 people, 18.18%
  5. Furosemide: 1 person, 9.09%
  6. Lipitor: 1 person, 9.09%
  7. Levothyroxine Sodium: 1 person, 9.09%
  8. Levofloxacin: 1 person, 9.09%
  9. Lansoprazole: 1 person, 9.09%
  10. Heparin: 1 person, 9.09%

What are other side effects people have besides Multi-organ failure? *

  1. Diarrhea: 5 people, 45.45%
  2. Haematochezia (passage of stools containing blood): 4 people, 36.36%
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 4 people, 36.36%
  4. Anaemia (lack of blood): 4 people, 36.36%
  5. Bleeding Into The Skin: 4 people, 36.36%
  6. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 4 people, 36.36%
  7. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 4 people, 36.36%
  8. Dizziness: 4 people, 36.36%
  9. Drug Toxicity: 4 people, 36.36%
  10. Excoriation (to tear or wear off the skin of): 4 people, 36.36%

What are the existing conditions these people have? *

  1. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 4 people, 36.36%
  2. Suicide Attempt: 2 people, 18.18%
  3. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 18.18%
  4. Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 9.09%
  5. Pain: 1 person, 9.09%
  6. Otitis Media Acute (rapid inflammation of the middle ear): 1 person, 9.09%
  7. Nausea (feeling of having an urge to vomit): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cefpodoxime proxetil and have Multi-organ failure?

- Check whether Multi-organ failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefpodoxime proxetil:

Multi-organ failure treatments and more:

How severe was Multi-organ failure and when was it recovered:

Expand to all the drugs that have ingredients of cefpodoxime proxetil:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefpodoxime proxetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multi-organ failure:

Browse all the conditions that are associated with Multi-organ failure:


How the study uses the data?

The study uses data from the FDA. It is based on cefpodoxime proxetil (the active ingredients of Cefpodoxime proxetil) and Cefpodoxime proxetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: